FATE
Fate Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.48
+2.48%0
Insider buys (3m)
2
Insider sells (3m)
-$203.5K
Net value (3m)
+24.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 5, 2026 | Valamehr Bahram · director, officer: President and CEO | Sale | 43,947 | $2.46 |
| Aug 5, 2026 | TAHL CINDY · officer: See Remarks | Sale | 38,800 | $2.46 |
| Jun 15, 2026 | Xu Yuan · director | A-Award | 87,900 | $2.06 |
| Jun 15, 2026 | Redmile Group, LLC · director, 10 percent owner: | A-Award | 87,900 | $2.06 |
| Jun 15, 2026 | Agarwal Shefali · director | A-Award | 87,900 | $2.06 |
| Jun 15, 2026 | EPSTEIN ROBERT S · director | A-Award | 87,900 | $2.06 |
| Jun 15, 2026 | Hamill Laura · director | A-Award | 175,800 | $2.06 |
| Jun 15, 2026 | RASTETTER WILLIAM H · director | A-Award | 87,900 | $2.06 |
| Jun 15, 2026 | Lee Michael Stewart · director | A-Award | 87,900 | $2.06 |
| Jun 15, 2026 | Jooss Karin · director | A-Award | 87,900 | $2.06 |
| Jun 15, 2026 | ABERNETHY MATT · director | A-Award | 87,900 | $2.06 |
| May 21, 2026 | Valamehr Bahram · director, officer: President and CEO | Sale | 28,946 | $1.88 |
| May 21, 2026 | TAHL CINDY · officer: See Remarks | Sale | 25,590 | $1.88 |
| May 7, 2026 | TAHL CINDY · officer: See Remarks | M-Exempt | 122,220 | $1.32 |
| May 7, 2026 | TAHL CINDY · officer: See Remarks | M-Exempt | 44,444 | $1.05 |
| May 6, 2026 | EPSTEIN ROBERT S · director | M-Exempt | 25,000 | $1.69 |
| May 6, 2026 | RASTETTER WILLIAM H · director | M-Exempt | 25,000 | $1.69 |
| Jan 16, 2026 | Adawi Kamal · officer: Chief Financial Officer | A-Award | 25,000 | $0.00 |
| Jan 16, 2026 | TAHL CINDY · officer: See Remarks | A-Award | 100,000 | $0.00 |
| Jan 16, 2026 | Valamehr Bahram · director, officer: President and CEO | A-Award | 335,000 | $0.00 |
| Jan 16, 2026 | Valamehr Bahram · director, officer: President and CEO | A-Award | 1,300,000 | $1.05 |
| Jan 16, 2026 | TAHL CINDY · officer: See Remarks | A-Award | 400,000 | $1.05 |
| Jan 16, 2026 | Adawi Kamal · officer: Chief Financial Officer | A-Award | 75,000 | $1.05 |
| Jan 12, 2026 | TAHL CINDY · officer: See Remarks | Sale | 10,589 | $1.06 |
| Jan 12, 2026 | Valamehr Bahram · director, officer: President and CEO | Sale | 5,190 | $1.07 |
| Oct 21, 2025 | Adawi Kamal · officer: Chief Financial Officer | A-Award | 75,000 | $0.00 |
| Oct 21, 2025 | Adawi Kamal · officer: Chief Financial Officer | A-Award | 375,000 | $1.54 |
| Aug 5, 2025 | TAHL CINDY · officer: See Remarks | Sale | 9,037 | $1.06 |
| Aug 5, 2025 | Valamehr Bahram · director, officer: President and CEO | Sale | 14,466 | $1.06 |
| May 30, 2025 | Xu Yuan · director | A-Award | 55,000 | $1.32 |
Institutional positioning
13F filings over the trailing two quarters
New 58Increased 113Reduced 74Sold out 30
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Redmile Group, LLC | Unchanged | 12,872,946 | Aug 14, 2026 |
| REDMILE GROUP, LLC | Unchanged | 12,872,946 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 10,068,614 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 7,298,895 | Aug 7, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 4,545,893 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,445,536 | Aug 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 4,351,250 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,192,063 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4,134,585 | May 8, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 4,120,200 | May 13, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 3,837,229 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 3,589,863 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 3,466,786 | May 15, 2026 |
| JOHNSON & JOHNSON | Reduced | 3,379,064 | May 13, 2026 |
| JOHNSON & JOHNSON | Unchanged | 3,379,064 | Mar 18, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 5, 2026